Emerging Biomarkers for Prediabetes : A Review
DOI:
https://doi.org/10.56260/sciena.v4i6.278Keywords:
Prediabetes, recent biomarkersAbstract
Prediabetes is a global health concern marked by elevated blood glucose levels that do not yet meet the threshold for type 2 diabetes mellitus (T2DM). It is often underdiagnosed despite being associated with insulin resistance, beta-cell dysfunction, and increased cardiovascular risk. Improved strategies for early detection are crucial to prevent disease progression. This review aims to explore novel biomarkers associated with prediabetes and evaluate their potential clinical applications in early diagnosis and risk stratification. A literature search was conducted on English and Indonesian language publications, including original research, case reports, and expert guidelines, focusing on emerging molecular and metabolic biomarkers related to prediabetes. Several promising biomarkers have been identified, including adiponectin, microRNAs, fetuin A, alpha-hydroxybutyrate (α-HB), and Protein Z. Adiponectin demonstrates an inverse relationship with insulin resistance. Specific microRNAs, such as miR-192 and miR-193b, are implicated in glucose metabolism and beta-cell function. Elevated fetuin A levels are linked to hepatic insulin resistance, while increased α-HB levels reflect early metabolic shifts in glucose utilization. Additionally, altered Protein Z concentrations may contribute to prothrombotic states in individuals with prediabetes. In conclusion, these biomarkers offer valuable insight into the pathophysiology of prediabetes and hold potential for enhancing early detection and prevention strategies. However, further validation through large-scale studies is needed before their integration into clinical practice
References
. Decroli E. Prediabetes. Padang: Andalas University Press; 2022. 146 p. ISBN: 978-623-172-002-3.
. Decroli E, Efendi YP, Kam A, Manaf A, Syahbuddin S. Description of Insulin Resistance and Beta-Cell Pancreas Dysfunction in Prediabetic Patients. ICOMHER. 2018
. Echouffo-Tcheugui JB, Selvin E. Prediabetes and What It Means: The Epidemiological Evidence. Annu Rev Public Health. 2021;42:59- 77
. International Diabetes Federation. IDF Diabetes Atlas, 9th edition. Brussels, Belgium, International Diabetes Federation. 2019
. Center for Disease Control and Prevention. Prevalence prediabetes of among adults. 2022
. Dorcely B, Katz K, Jagannathan R. Novel biomarkers for prediabetes, diabetes, and associated complications. Diabetes Metab Syndr Obes. 2017;10:345-361
. Díaz-Redondo A, Giráldez-García C, Carrillo L, et al. Modifiable risk factors associated with prediabetes in men and women: a cross- sectional analysis of the cohort study in primary health care on the evolution of patients with prediabetes BMC Fam Pract. 2015;16:5
. Persatuan Diabetes Indonesia. Pengelolaan dan pencegahan prediabetes di Indonesia. 2019
. Abdella NA, Mojiminiyi OA. Clinical applications of adiponectin measurements in type 2 diabetes mellitus: Screening, diagnosis, and marker of diabetes control. Dis Markers. 2018.
. Khoramipour K, Chamari K, Hekmatikar AA, Ziyaiyan A, Taherkhani S, Elguindy NM, et al. Adiponectin: Structure, Physiological Functions, Role in Diseases, and Effects of Nutrition. Nutrients. 2021;13(4):1180.
. Ganesh V, M M, Palem SP. Adiponectin Can Be an Early Predictable Marker for Type 2 Diabetes Mellitus and Nephropathy. Cureus. 2022;14(7).
. Lin D, Hong X, Sun K, Zhang X, Lian H, Wang J, et al. Galectin-3/adiponectin as a new biological indicator for assessing the risk of type 2 diabetes: a cross-sectional study in a community population.Aging. 2021;13(11):15433–43.
. Nguyen TMD. Adiponectin: Role in Physiology and Pathophysiology. Int J Prev Med. 2020;11:136
. Al-Kafaji G, Al-Muhtaresh HA, Salem AH. Expression and clinical significance of mir-1 and mir-133 in pre-diabetes. Biomed Rep. 2021;14(3):1–9.
. Sidorkiewicz I, Niemira M, Maliszewska K, Erol A, Bielska A, Szalkowska A, et al. Circulating mirnas as a predictive biomarker of the progression from prediabetes to diabetes: Outcomes of a 5-year prospective observational study. J Clin Med. 2020;9(7):1– 20.
. Yan LN, Zhang X, Xu F, Fan YY, Ge B, Guo H, et al. Four-microRNA signature for detection of type 2 diabetes. World J Clin Cases. 2020;8(10):1923–31.
. Bodaghi A, Fattahi N, Ramazani A. Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases. Heliyon. 2023;9(2):e13323.
. Luís C, Baylina P, Soares R, Fernandes R. Metabolic dysfunction biomarkers as predictors of early diabetes. Biomolecules. 2021;11(11).
. Ahn MB, Kim SK, Kim SH, Cho WK, Suh JS, Cho KS, et al. Clinical significance of the fetuin-a-to- adiponectin ratio in obese children and adolescents with diabetes mellitus. Children. 2021;8(12).
. Wang Y, Koh WP, Jensen MK, Yuan JM, Pan A. Plasma fetuin-A levels and risk of type 2 diabetes mellitus in a Chinese population: A nested case-control study. Diabetes Metab J. 2019;43(4):474–86.
. Susairaj P, Snehalatha C, Nanditha A, Satheesh K, Raghavan A, Vinitha R, et al. Analysis of an Indian diabetes prevention programme on association of adipokines and a hepatokine with incident diabetes. Sci Rep. 2021;11(1):1—9.
. Khathi A, Dagogo-Jack S. Editorial: Prediabetes and endocrine function. Front Endocrinol (Lausanne). 2023;14(8):1–3.
. Luís C, Soares R, Baylina P, Fernandes R. Underestimated Prediabetic Biomarkers: Are We Blind to Their Strategy? Front Endocrinol (Lausanne). 2022;13(3):1–7
. Gall WE, Beebe K, Lawton KA, Adam KP, Mitchell MW, Nakhle PJ, et al. Α- Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population. PLoS One. 2010;5(5).
. Cobb J, Eckhart A, Motsinger-Reif A, Carr B, Groop L, Ferrannini E. α-Hydroxybutyric acid is a selective metabolite biomarker of impaired glucose tolerance. Diabetes Care. 2016;39(6):988–95
. Almawi, W. Y., Al-Shaikh, F. S., Melemedjian, O. K., Almawi, A. W. Protein Z, an anticoagulant protein with expanding role in reproductive biology. REPRODUCTION, 2013; 146(2), R73- R80
. Bae YU, You JH, Cho NH. Association of Protein Z with Prediabetes and Type 2 Diabetes. Endocrinol Metab (Seoul). 2021;36(3):637- 646Hazel K, O’Conor A. Emerging treatments for inflammatory bowel
. Anggraini, D., Yaswir, R., Lillah, L., & Husni, H. (2017). Correlation of Advanced Glycation End Products with Urinary Albumin Creatinin Ratio in Patients with Type 2 Diabetes Mellitus. Indonesian Journal of Clinical Pathology and Medical Laboratory, 23(2), 107-110.
. Anggraini, D., & Zakiyah, N. J. (2024). Risk Factors of Type 2 Diabetes Mellitus in the Elderly. Nusantara Hasana Journal, 3(10), 34-40.
. Anggraini, D., Yaswir, R., Lillah, L., & Husni, H. (2017). Correlation of Advanced Glycation End Products with Urinary Albumin Creatinin Ratio in Patients with Type 2 Diabetes Mellitus. Indonesian Journal of Clinical Pathology and Medical Laboratory, 23(2), 107-110.
. Anggraini, D., & Zakiyah, N. J. (2024). Risk Factors of Type 2 Diabetes Mellitus in the Elderly. Nusantara Hasana Journal, 3(10), 34-40.
. Anggraini, D., Amran, R., & Adelin, P. (2023). Deteksi Dini Hiperglikemia pada Lansia Binaan Puskesmas Guguak Kabupaten 50 Kota. Jurnal Pengabdian Masyarakat Kesehatan (JURABDIKES), 1(1), 05-08.
. Anggraini, D., Oktora, M. Z., & Hasni, D. (2025). Peran Indeks Aterogenik sebagai Penanda Komplikasi pada Diabetes Melitus Tipe 2: Tinjauan Pustaka. Scientific Journal, 4(2), 91-99.
. Anggraini, D., Amran, R., & Adelin, P. (2023). Deteksi Dini Hiperglikemia pada Lansia Binaan Puskesmas Guguak Kabupaten 50 Kota. Jurnal Pengabdian Masyarakat Kesehatan (JURABDIKES), 1(1), 05-08.
. Anggraini, D., Oktora, M. Z., & Hasni, D. (2025). Peran Indeks Aterogenik sebagai Penanda Komplikasi pada Diabetes Melitus Tipe 2: Tinjauan Pustaka. Scientific Journal, 4(2), 91-99.
. Febryan R, Decroli E, Aprilia D, Kam A. Pemeriksaan 1,5-Anhydroglucitol, Suatu Hal Baru dalam Pemeriksaan Prediabetes. Maj Kedokteran Andalas. 2023 Jul;46(4):724-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dinda Aprilia , Eva Decroli, Alexander Kam, Putri Deas Hadilofyani
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
